Treatment With Lenalidomide, Bendamustine and Prednisone (RBP) in Patients With Relapsed or Refractory Multiple Myeloma
Define maximum tolerable dose of the combination lenalidomide, bendamustine, prednisone.
Multiple Myeloma
DRUG: Lenalidomide, Bendamustine, Prednisone
To determine the maximum tolerable dose (MTD) of lenalidomide in combination with bendamustine and prednisone (RBP) in refractory and relapsed MM stage I/III, 2 month
To determine the safety of lenalidomide, bendamustine and prednisone at MTD, 2 years
Define maximum tolerable dose of the combination lenalidomide, bendamustine, prednisone.